Drug Database
DI

diclofenac (diclofenac, Klinge / Viavox divido / Deflamat forte)

✓ Approved

Teva Pharmaceutical Industries Ltd. · PTGS1 · 小分子

什么是 diclofenac?

diclofenac 是一种小分子,由Teva Pharmaceutical Industries Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名diclofenac, Klinge, Viavox divido, Deflamat forte
公司Teva Pharmaceutical Industries Ltd.
药物类别小分子
分子靶点PTGS1, PTGS2
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

diclofenac 作用于 2 个分子靶点:

PTGS1prostaglandin-endoperoxide synthase 1 (COX3, PCOX1)
PTGS2prostaglandin-endoperoxide synthase 2 (GRIPGHS, hCox-2)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

diclofenac 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Gastrointestinal disordersAbdominal pain✓ Approved

相关研究文献

PubMedDrug development and industrial pharmacy2026-11-17

Integrating AI-Guided Design with Experimental Validation for Niosome-Based Drug Delivery Systems.

Salem Yasmein Yaser YY, Hourani Joud J, Al Rfai Ranim R, Abdelgawwad Sara S et al.

To develop and experimentally validate an explainable artificial intelligence (AI) framework that extracts formulation rules for niosomal drug delivery systems from published data and delivers them through a decision-support platform. Niosome performance depends on many interacting formulation and process variables, and optimization still relies largely on trial-and-error experimentation. Converting existing formulation knowledge into interpretable, experimentally verified rules could make early-stage development faster and less resource-intensive. A database of 33 optimized niosomal formulations (approximately 30 drugs, BCS classes I-V) was compiled from peer-reviewed studies. Correlation analysis, XGBoost feature importance, and SHAP were used to relate formulation variables to particle size, entrapment efficiency (EE%), drug release, and release time. The extracted trends were tested experimentally using 17 diclofenac sodium-loaded niosomal formulations prepared by thin-film hydration. The dataset was expanded to 1000 samples using SMOTE to train XGBoost predictive models, which were evaluated on the original formulations and integrated with a Qwen-based large language model. Phosphate-buffered saline as the hydration medium, Span 60, and chloroform volume were the most influential variables. Laboratory results agreed with the AI-predicted direction of effect for all tested variables: cholesterol, Span 60, chloroform volume, Tween 80, and hydration medium. The predictive models achieved R2 values of 0.97-0.99 on the original formulations, and the resulting Niosome AI Expert platform showed general agreement between predicted and reported outcomes. Combining machine learning, explainable AI, and experimental verification can convert existing formulation knowledge into a practical decision-support tool that reduces reliance on trial-and-error niosome development.

PMID 43043099
阅读全文 →
PubMedProstaglandins & other lipid mediators2026-11-16

Ameliorating effects of ferulic acid on oxidative stress and COX-2 activity in human peripheral blood exposed in vitro to X-rays.

Amshumala B L BL, Pavan G G, Shetty Deeksha D, Vishakh R R et al.

This study aims to identify novel antioxidant-based anti-inflammatory molecules that scavenge free radicals, reduce oxidative stress, and inhibit COX-2 expression, offering safer therapeutic alternatives. The antioxidant-based molecules were identified using computational approaches and validated in ex vivo studies. PTGS2-ferulic acid complex showed 1 hydrogen bond with a binding energy of -6.5kcal/mol with a bond distance of 2.93Å, whereas PTGS2-diclofenac complex, which contains 1 hydrogen bond, has a binding energy of -6.8kcal/mol with a bond distance of 3.27Å. Ferulic acid with PTGS2 forms the highest binding free energy (-73.1kJ/mol) when compared to diclofenac, a well-established COX-2 inhibitor (-60.4kJ/mol). Compared to the radiation group, the ferulic acid + radiation group exhibited a significant (p<0.001) decrease in malondialdehyde, glutathione reductase and COX-2 levels and an increase (p<0.05) in superoxide dismutase levels. The results of this study suggest that ferulic acid mitigates oxidative stress and COX-2 expression, enhances antioxidant defences and anti-inflammatory properties, indicating its potential as a pharmacological agent for preventing radiation-induced damage.

PMID 43035172
阅读全文 →
PubMedJournal of hazardous materials2026-11-16

Coupling conductive media with low-voltage electrochemical stimulation in anaerobic fluidized bed membrane bioreactors for diclofenac removal and bioenergy recovery.

Bazmi Zulqarnain Aqeel ZA, Park Soojin S, Kim Jeonghwan J

Diclofenac (DCF), a widely used non-steroidal anti-inflammatory drug, is a persistent pharmaceutical contaminant of emerging environmental concern. To overcome this limitation, an electro-assisted anaerobic fluidized bed membrane bioreactor (E-AFMBR) was developed, incorporating magnetite-coated granular activated carbon (MGAC) as a conductive fluidized biocarrier to combine adsorption, electrochemical transformation, and anaerobic biodegradation in single treatment system. Batch experiments were first conducted to isolate the individual contributions of removal mechanisms. The MGAC only achieved 90% DCF removal via adsorption, compared to the 75% for unmodified GAC. Langmuir isotherm analysis confirmed higher adsorption capacity and affinity for DCF. Biomass itself removed only 43% of DCF under anaerobic environment, whereas electrochemical treatment itself achieved 96%, identifying electrochemical transformation as the predominant removal pathway. Combining biomass, MGAC, and an applied electric field together in anaerobic batch reactor raised removal significantly to 99%. During 150 days of continuous E-AFMBR operation, the DCF removal declined progressively without external voltage due to the adsorption-site saturation, whereas applying 1.0 V sustained more than 98% of removal efficiency. The E-AFMBR system fed with DCF produced biogas containing 67.4% methane, with a methane yield of 0.328 L CH₄ g⁻¹ SCOD removed and energy balance of + 432%.

PMID 43038825
阅读全文 →
PubMedIn vitro models2026-11-15

Dromedary hump oil: From its physicochemical characterization to, anti-inflammatory, wound healing and antinociceptive potentials.

Ishagh Beybeti B, Tbatou Widad W, ElGhouizi Asmae A, Elaraj Tarik T et al.

Man has always been prone to burns due to his daily contact with various causes, whether at home, at work, in a plane crash, in a car accident, in war, in bushfires, or elsewhere. For several years, dromedary hump oil, derived from the hump of Camelus dromedarius, has been known in North Africa for its beneficial properties, especially in dermatological contexts. It has been used to treat burns, dermal infections, chronic wounds, and atopic dermatitis. Honey is considered one of the most effective natural ointments for burns and wounds. This study aims to evaluate the anti-inflammatory, wound-healing, and antinociceptive properties of the crude hump oil of Camelus dromedarius, as well as its physicochemical characterization. Also, we aimed to compare hump oil capacity to treat wounds to thyme honey. Our physical characterization results showed: fat content, 99.78 g⁄100 g; free fatty acids (as oleic acid), 0.48 g⁄100 g; peroxide value, 0.85 Meq. O2/kg; iodine value 46,9 g⁄100 g; density, 0,840 and viscosity, 93.20cP at 20 °C. Besides, the anti-inflammatory effect of dromedary hump oil against carrageenan-induced paw edema showed 92% inhibition at the 6th hour, compared to Diclofenac, which showed 90% inhibition at the same hour. Moreover, the antinociceptive test of dromedary hump oil against acetic acid showed 95% protection, higher than that of Tramadol (91%).

PMID 43034352
阅读全文 →
PubMedDrug testing and analysis2026-11-14

Diclofenac in Urine Samples Deactivates the GC/C/IRMS Reactor and Compromises the Determination of δ13C Values of Steroids.

Mengmeng Yan Y, Chao Wen W, Kuan Yan Y, Tianshuo Zhu Z et al.

Gas chromatography/combustion/isotope ratio mass spectrometry (GC/C/IRMS) is used as a confirmation procedure for detecting the administration of synthetic forms of endogenous anabolic androgenic steroids (EAAS) by comparing the carbon isotope ratios (δ13C) of target compounds (TCs) with those of endogenous reference compounds (ERCs). In recent years, some samples have been found to still contain interfering matrix components in different TC/ERC fractions after HPLC purification, which can rapidly deactivate the GC/C/IRMS reactor. 1-(2,6-Dichlorophenyl)indolin-2-one (1-(DCP)I) has been identified as a major contributor to reactor deactivation. Subsequent studies suggested that 1-(DCP)I was associated with diclofenac (DCF), a major metabolite formed following DCF sodium administration. DCF can persist in target fractions even after purification by one- or two-dimensional semipreparative liquid chromatography coupled with fraction collection. During subsequent GC/C/IRMS analysis, residual chlorinated substances in purified fractions may contribute to oxidation reactor deactivation, thereby interfering with the determination of analyte 's δ13C values. Optimization of the backflush time in the GC/C/IRMS system can effectively minimize the influence of these chlorine-containing substances on analysis.

PMID 43031380
阅读全文 →
PubMedInternational journal of molecular sciences2026-11-14

Diclofenac Removal by Actinobacterial Strains and Ecotoxicological Responses.

Gonzalez Holc Victoria Guadalupe VG, Small María Alejandra MA, Arnau Gonzalo G, Lautru Sylvie S et al.

Diclofenac (DCF) is a widely detected pharmaceutical whose persistence and biologically active transformation products raise environmental concern. This study evaluated DCF tolerance and removal by actinobacterial strains and integrated chemical performance with plant- and earthworm-based ecotoxicological responses. Phenotypic screening at 1, 5, and 10 g L-1 DCF revealed strain- and concentration-dependent responses in growth, sporulation, and pigment production, with Streptomyces sp. E5N50 and Streptomyces sp. Z2 selected for further study. In liquid assays, after 5 days of incubation, only low biomass production was observed when 50 mg L-1 DCF was supplied without glucose, relative to glucose-containing controls. E5N50 showed modest DCF removal (approximately 23-26%), while Z2 achieved 90.8% in glucose-supplemented medium and about 70% when glucose and ammonium were supplied. A seven-day time-course study with Streptomyces sp. Z2 showed that DCF removal continued after biomass had reached its maximum, suggesting that the process was not exclusively growth-associated. Ecotoxicological responses were organism- and endpoint-dependent. The glucose + DCF + Z2 treatment, associated with the highest DCF removal, significantly increased tomato radicle elongation, whereas glucose + ammonium + DCF + Z2 produced the most favorable Eisenia fetida response, with significantly reduced body-mass loss and increased coelomocyte abundance despite the lower DCF removal removalobserved in this treatment. Overall, Z2 exhibited potential for DCF removal under defined laboratory liquid-culture conditions, and the combined chemical and biological assessment highlighted that parent-compound removal and ecotoxicological improvement provide complementary measures of remediation performance.

PMID 43028197
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多diclofenac